Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plans

v3.21.1
Equity Incentive Plans
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Equity Incentive Plans

Note 12. Equity Incentive Plans

Stock options:

A summary of option activities under the 2005 Plan and 2017 Plan during the three months ended March 31, 2021 is as follows:

 

 

 

Number
of Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

Outstanding as of December 31, 2020

 

 

813,242

 

 

$

24.58

 

Granted

 

 

65,132

 

 

$

38.46

 

Exercised

 

 

(60,600

)

 

$

3.53

 

Canceled

 

 

(3,234

)

 

$

40.11

 

Outstanding as of March 31, 2021

 

 

814,540

 

 

$

27.20

 

 

Restricted stock units:

A summary of restricted stock unit ("RSU") activities under the 2017 Plan during the three months ended March 31, 2021 is as follows:

 

 

 

Number of Restricted Stock Units

 

 

Weighted
Average
Grant Date Fair Value per RSU

 

 

Nonvested at December 31, 2020

 

 

141,508

 

 

$

29.67

 

 

Granted

 

 

64,408

 

 

$

37.26

 

 

Vested

 

 

(24,332

)

 

$

22.21

 

 

Nonvested at March 31, 2021

 

 

181,584

 

 

$

33.36

 

 

 

2017 Employee Stock Purchase Plan

There were no shares issued under the 2017 ESPP during the three months ended March 31, 2021 as there was no purchase date during this period.

Total stock-based compensation expense associated with the 2005 Plan, 2017 Plan and 2017 ESPP is recorded in the condensed consolidated statements of operations and was allocated as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Cost of revenues

 

$

392

 

 

$

217

 

Sales and marketing

 

 

371

 

 

 

256

 

Research and development

 

 

181

 

 

 

102

 

General and administrative

 

 

431

 

 

 

312

 

Total

 

$

1,375

 

 

$

887